{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:07:59Z","timestamp":1790197679168,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"2A Biosciences; Eleusis Therapeutics"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1038\/s41386-025-02272-3","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T23:22:17Z","timestamp":1762989737000},"page":"641-649","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Psychedelics produce enduring behavioral effects and functional plasticity through mechanisms independent of structural plasticity"],"prefix":"10.1038","volume":"51","author":[{"given":"Hannah M.","family":"Kramer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9394-9789","authenticated-orcid":false,"given":"Meghan","family":"Hibicke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaina M.","family":"Jaster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper L.","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0615-0646","authenticated-orcid":false,"given":"Charles D.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"2272_CR1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/0269881119897615","volume":"34","author":"GI Agin-Liebes","year":"2020","unstructured":"Agin-Liebes GI, Malone T, Yalch MM, Mennenga SE, Pont\u00e9 KL, Guss J, et al. Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer. J Psychopharmacol. 2020;34:155\u201366.","journal-title":"J Psychopharmacol"},{"key":"2272_CR2","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1177\/0269881116675513","volume":"30","author":"RR Griffiths","year":"2016","unstructured":"Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD, et al. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial. J Psychopharmacol. 2016;30:1181\u201397.","journal-title":"J Psychopharmacol"},{"key":"2272_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","volume":"68","author":"CS Grob","year":"2011","unstructured":"Grob CS, Danforth AL, Chopra GS, Hagerty M, McKay CR, Halberstadt AL, et al. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Arch Gen Psychiatry. 2011;68:71.","journal-title":"Arch Gen Psychiatry"},{"key":"2272_CR4","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1177\/0269881116675512","volume":"30","author":"S Ross","year":"2016","unstructured":"Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B, et al. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. J Psychopharmacol. 2016;30:1165\u201380.","journal-title":"J Psychopharmacol"},{"key":"2272_CR5","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/S0893-133X(01)00405-5","volume":"26","author":"C Nichols","year":"2002","unstructured":"Nichols C. A single dose of lysergic acid diethylamide influences gene expression patterns within the mammalian brain. Neuropsychopharmacology. 2002;26:634\u201342.","journal-title":"Neuropsychopharmacology"},{"key":"2272_CR6","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S0169-328X(03)00029-9","volume":"111","author":"CD Nichols","year":"2003","unstructured":"Nichols CD, Garcia EE, Sanders-Bush E. Dynamic changes in prefrontal cortex gene expression following lysergic acid diethylamide administration. Mol Brain Res. 2003;111:182\u20138.","journal-title":"Mol Brain Res"},{"key":"2272_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109836","volume":"37","author":"M de la Fuente Revenga","year":"2021","unstructured":"de la Fuente Revenga M, Zhu B, Guevara CA, Naler LB, Saunders JM, Zhou Z, et al. Prolonged epigenomic and synaptic plasticity alterations following single exposure to a psychedelic in mice. Cell Rep. 2021;37:109836.","journal-title":"Cell Rep"},{"key":"2272_CR8","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","volume":"23","author":"C Ly","year":"2018","unstructured":"Ly C, Greb AC, Cameron LP, Wong JM, Barragan EV, Wilson PC, et al. Psychedelics promote structural and functional neural plasticity. Cell Rep. 2018;23:3170\u201382.","journal-title":"Cell Rep"},{"key":"2272_CR9","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1016\/j.neuron.2021.06.008","volume":"109","author":"L-X Shao","year":"2021","unstructured":"Shao L-X, Liao C, Gregg I, Davoudian PA, Savalia NK, Delagarza K, et al. Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo. Neuron. 2021;109:2535\u20132544.e4.","journal-title":"Neuron"},{"key":"2272_CR10","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3390\/ijms22020835","volume":"22","author":"NR Raval","year":"2021","unstructured":"Raval NR, Johansen A, Donovan LL, Ros NF, Ozenne B, Hansen HD, et al. A single dose of psilocybin increases synaptic density and decreases 5-HT2A receptor density in the pig brain. Int J Mol Sci. 2021;22:835.","journal-title":"Int J Mol Sci"},{"key":"2272_CR11","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.2174\/1570159X21666221129120902","volume":"21","author":"EE Redei","year":"2023","unstructured":"Redei EE, Udell ME, Solberg Woods LC, Chen H. The Wistar Kyoto Rat: a model of depression traits. Curr Neuropharmacol. 2023;21:1884\u2013905.","journal-title":"Curr Neuropharmacol"},{"key":"2272_CR12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1089\/psymed.2022.0008","volume":"1","author":"DE Nichols","year":"2023","unstructured":"Nichols DE, Nichols CD, Hendricks PS. Proposed consensus statement on defining psychedelic drugs. Psychedelic Med. 2023;1:12\u201313.","journal-title":"Psychedelic Med"},{"key":"2272_CR13","doi-asserted-by":"publisher","first-page":"8106","DOI":"10.1073\/pnas.1414728112","volume":"112","author":"M Fuchikami","year":"2015","unstructured":"Fuchikami M, Thomas A, Liu R, Wohleb ES, Land BB, DiLeone RJ, et al. Optogenetic stimulation of infralimbic PFC reproduces ketamine\u2019s rapid and sustained antidepressant actions. Proc Natl Acad Sci USA. 2015;112:8106\u201311.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2272_CR14","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/0091-3057(77)90180-0","volume":"6","author":"M Davis","year":"1977","unstructured":"Davis M, Walters JK. Psilocybin: biphasic dose-response effects on the acoustic startle reflex in the rat. Pharm Biochem Behav. 1977;6:427\u201331.","journal-title":"Pharm Biochem Behav"},{"key":"2272_CR15","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1021\/acschemneuro.9b00493","volume":"11","author":"M Hibicke","year":"2020","unstructured":"Hibicke M, Landry AN, Kramer HM, Talman ZK, Nichols CD. Psychedelics, but not ketamine, produce persistent antidepressant-like effects in a rodent experimental system for the study of depression. ACS Chem Neurosci. 2020;11:864\u201371.","journal-title":"ACS Chem Neurosci"},{"key":"2272_CR16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1089\/psymed.2022.0012","volume":"1","author":"M Hibicke","year":"2023","unstructured":"Hibicke M, Kramer HM, Nichols CD. A single administration of psilocybin persistently rescues cognitive deficits caused by adolescent chronic restraint stress without long-term changes in synaptic protein gene expression in a rat experimental system with translational relevance to depression. Psychedelic Med. 2023;1:54\u201367.","journal-title":"Psychedelic Med"},{"key":"2272_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.113979","volume":"177","author":"AA Jensen","year":"2020","unstructured":"Jensen AA, Halberstadt AL, M\u00e4rcher-R\u00f8rsted E, Odland AU, Chatha M, Speth N, et al. The selective 5-HT2A receptor agonist 25CN-NBOH: structure-activity relationship, in vivo pharmacology, and in vitro and ex vivo binding characteristics of [3H]25CN-NBOH. Biochem Pharm. 2020;177:113979.","journal-title":"Biochem Pharm"},{"key":"2272_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000012307","volume":"68","author":"T Uehara","year":"1999","unstructured":"Uehara T, Sakado K, Sakado M, Sato T, Someya T. Relationship between stress coping and personality in patients with major depressive disorder. Psychother Psychosom. 1999;68:26\u201330.","journal-title":"Psychother Psychosom"},{"key":"2272_CR19","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1080\/026990500445718","volume":"14","author":"FinsetA Andersson","year":"2000","unstructured":"Andersson FinsetA. S. Coping strategies in patients with acquired brain injury: relationships between coping, apathy, depression and lesion location. Brain Inj. 2000;14:887\u2013905.","journal-title":"Brain Inj"},{"key":"2272_CR20","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3109\/01612840.2011.632708","volume":"33","author":"JSR Mahmoud","year":"2012","unstructured":"Mahmoud JSR, Staten RT, Hall LA, Lennie TA. The relationship among young adult college students\u2019 depression, anxiety, stress, demographics, life satisfaction, and coping styles. Issues Ment Health Nurs. 2012;33:149\u201356.","journal-title":"Issues Ment Health Nurs"},{"key":"2272_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1084\/jem.188.1.157","volume":"188","author":"J-A Gonzalo","year":"1998","unstructured":"Gonzalo J-A, Lloyd CM, Wen D, Albar JP, Wells TNC, Proudfoot A, et al. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. J Exp Med. 1998;188:157\u201367.","journal-title":"J Exp Med"},{"key":"2272_CR22","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.2147\/NDT.S175973","volume":"14","author":"E Tsujimoto","year":"2018","unstructured":"Tsujimoto E, Tsujii N, Mikawa W, Ono H, Shirakawa O. Discrepancies between self- and observer-rated depression severities in patients with major depressive disorder associated with frequent emotion-oriented coping responses and hopelessness. Neuropsychiatr Dis Treat. 2018;14:2331\u20136.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2272_CR23","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1021\/acschemneuro.7b00042","volume":"8","author":"KG Commons","year":"2017","unstructured":"Commons KG, Cholanians AB, Babb JA, Ehlinger DG. The rodent forced swim test measures stress-coping strategy, not depression-like behavior. ACS Chem Neurosci. 2017;8:955\u201360.","journal-title":"ACS Chem Neurosci"},{"key":"2272_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.yhbeh.2017.07.011","volume":"95","author":"M Kent","year":"2017","unstructured":"Kent M, Bardi M, Hazelgrove A, Sewell K, Kirk E, Thompson B, et al. Profiling coping strategies in male and female rats: potential neurobehavioral markers of increased resilience to depressive symptoms. Horm Behav. 2017;95:33\u201343.","journal-title":"Horm Behav"},{"key":"2272_CR25","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3109\/10253890.2011.614296","volume":"15","author":"Y Ono","year":"2012","unstructured":"Ono Y, Lin H-C, Tzen K-Y, Chen H-H, Yang P-F, Lai W-S, et al. Active coping with stress suppresses glucose metabolism in the rat hypothalamus. Stress. 2012;15:207\u201317.","journal-title":"Stress"},{"key":"2272_CR26","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1742-7843.2009.00516.x","volume":"106","author":"C Dalla","year":"2010","unstructured":"Dalla C, Pitychoutis PM, Kokras N, Papadopoulou-Daifoti Z. Sex differences in animal models of depression and antidepressant response. Basic Clin Pharm Toxicol. 2010;106:226\u201333.","journal-title":"Basic Clin Pharm Toxicol"},{"key":"2272_CR27","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1017\/S1461145714000212","volume":"17","author":"N Kokras","year":"2014","unstructured":"Kokras N, Pastromas N, Porto TH, Kafetzopoulos V, Mavridis T, Dalla C. Acute but not sustained aromatase inhibition displays antidepressant properties. Int J Neuropsychopharmacol. 2014;17:1307\u201313.","journal-title":"Int J Neuropsychopharmacol"},{"key":"2272_CR28","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/nprot.2012.044","volume":"7","author":"DA Slattery","year":"2012","unstructured":"Slattery DA, Cryan JF. Using the rat forced swim test to assess antidepressant-like activity in rodents. Nat Protoc. 2012;7:1009\u201314.","journal-title":"Nat Protoc"},{"key":"2272_CR29","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1037\/pha0000119","volume":"25","author":"M Hibicke","year":"2017","unstructured":"Hibicke M, Graham MA, Hayslett RL. Adolescent chronic restraint stress (aCRS) elicits robust depressive-like behavior in freely cycling, adult female rats without increasing anxiety-like behaviors. Exp Clin Psychopharmacol. 2017;25:74\u201383.","journal-title":"Exp Clin Psychopharmacol"},{"key":"2272_CR30","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.brainresbull.2010.12.012","volume":"84","author":"P Kandi","year":"2011","unstructured":"Kandi P, Hayslett RL. Nicotine and 17\u03b2-estradiol produce an antidepressant-like effect in female ovariectomized rats. Brain Res Bull. 2011;84:224\u20138.","journal-title":"Brain Res Bull"},{"key":"2272_CR31","doi-asserted-by":"crossref","unstructured":"Ting JT, Daigle TL, Chen Q, Feng G. Acute brain slice methods for adult and aging animals: application of targeted patch clamp analysis and optogenetics. Methods Mol Biol. 2014;1183:221\u201342.","DOI":"10.1007\/978-1-4939-1096-0_14"},{"key":"2272_CR32","unstructured":"Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 6th ed. Amsterdam; Boston: Academic Press\/Elsevier; 2007."},{"key":"2272_CR33","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1152\/jn.00570.2019","volume":"123","author":"EA Fucich","year":"2020","unstructured":"Fucich EA, Stielper ZF, Cancienne HL, Edwards S, Gilpin NW, Molina PE, et al. Endocannabinoid degradation inhibitors ameliorate neuronal and synaptic alterations following traumatic brain injury. J Neurophysiol. 2020;123:707\u201317.","journal-title":"J Neurophysiol"},{"key":"2272_CR34","unstructured":"Jolliffe IT. Principal component analysis. 2th ed. New York: Springer; 2010."},{"key":"2272_CR35","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9:671\u20135.","journal-title":"Nat Methods"},{"key":"2272_CR36","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nn.3917","volume":"18","author":"KD Harris","year":"2015","unstructured":"Harris KD, Shepherd GMG. The neocortical circuit: themes and variations. Nat Neurosci. 2015;18:170\u201381.","journal-title":"Nat Neurosci"},{"key":"2272_CR37","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.1002\/cmdc.202100395","volume":"16","author":"E M\u00e4rcher R\u00f8rsted","year":"2021","unstructured":"M\u00e4rcher R\u00f8rsted E, Jensen AA, Kristensen JL. 25CN-NBOH: a selective agonist for in vitro and in vivo investigations of the serotonin 2A receptor. ChemMedChem. 2021;16:3263\u201370.","journal-title":"ChemMedChem"},{"key":"2272_CR38","doi-asserted-by":"crossref","unstructured":"Jain MK, Gumpper RH, Slocum ST, Schmitz GP, Madsen JS, Tummino TA, et al. The polypharmacology of psychedelics reveals multiple targets for potential therapeutics. Neuron. 2025;113:3129\u201342.e9.","DOI":"10.1016\/j.neuron.2025.06.012"},{"key":"2272_CR39","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2022489118","volume":"118","author":"N Hesselgrave","year":"2021","unstructured":"Hesselgrave N, Troppoli TA, Wulff AB, Cole AB, Thompson SM. Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice. Proc Natl Acad Sci USA. 2021;118:e2022489118.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2272_CR40","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S0028-3908(97)00051-8","volume":"36","author":"GK Aghajanian","year":"1997","unstructured":"Aghajanian GK, Marek GJ. Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology. 1997;36:589\u201399.","journal-title":"Neuropharmacology"},{"key":"2272_CR41","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1017\/S0033291716000064","volume":"46","author":"T Kishimoto","year":"2016","unstructured":"Kishimoto T, Chawla JM, Hagi K, Zarate CA, Kane JM, Bauer M, et al. Single-dose infusion ketamine and non-ketamine N -methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories. Psychol Med. 2016;46:1459\u201372.","journal-title":"Psychol Med"},{"key":"2272_CR42","doi-asserted-by":"publisher","first-page":"ENEURO.0133","DOI":"10.1523\/ENEURO.0133-15.2016","volume":"3","author":"V Phoumthipphavong","year":"2016","unstructured":"Phoumthipphavong V, Barthas F, Hassett S, Kwan AC. Longitudinal effects of ketamine on dendritic architecture in vivo in the mouse medial frontal cortex. eNeuro. 2016;3:ENEURO.0133\u201315.2016.","journal-title":"eNeuro"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02272-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02272-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02272-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T23:03:17Z","timestamp":1769036597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02272-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2272"],"URL":"https:\/\/doi.org\/10.1038\/s41386-025-02272-3","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"10 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CDN is a founder and board member of 2A Biosciences. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}